Canada markets open in 8 hours 54 minutes

Sire Bioscience Inc. (BLLXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2352-0.0198 (-7.76%)
At close: 3:27PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 59M
Enterprise Value 310.82M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 334.40%
S&P500 52-Week Change 326.90%
52 Week High 30.2600
52 Week Low 30.0354
50-Day Moving Average 30.1448
200-Day Moving Average 30.1012

Share Statistics

Avg Vol (3 month) 3934
Avg Vol (10 day) 32.99k
Shares Outstanding 542.41M
Float 34.9M
% Held by Insiders 114.51%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct. 14, 2020

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Sep. 29, 2020
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.35%
Return on Equity (ttm)-123.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)94.53k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)740.80
Current Ratio (mrq)0.08
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A